BioCentury
ARTICLE | Financial News

Realm raises L19.3M

September 22, 2017 7:56 PM UTC

On Sept. 21, dermatology and ophthalmology company Realm Therapeutics plc (LSE:RLM) raised £19.3 million ($26.2 million) through the sale of 66.4 million units at 29p in a private placement to new and existing investors. New investors included OrbiMed, BVF Partners, RA Capital Management, Abingworth and Polar Capital. CEO Alex Martin and Charles Spicer, who is non-executive chairman of Realm, also participated in the placement. Each unit comprises a share and a two-and-a-half year warrant to purchase 0.4 shares, with each whole warrant exercisable at 58p...

BCIQ Company Profiles

Realm Therapeutics plc